Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients

This study determined the efficacy and safety of a modified FOLFOX regimen that improved patient convenience without compromising oxaliplatin dose intensity. A total of 62 patients with previously untreated metastatic colorectal cancer were enrolled to receive, entirely as outpatients, 2-weekly cycl...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Goldstein, D, Mitchell, P, Michael, M, Beale, P, Friedlander, M, Zalcberg, J, White, S, Clarke, S
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2005
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361919/
https://ncbi.nlm.nih.gov/pubmed/15756253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602426
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky